Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2022-10-24 Proxy Solicitation & In…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
PROPOSED MANDATE FOR POTENTIAL VERY SUBSTANTIAL DISPOSAL INVOLVING DISPOSAL OF PARTIAL INTERESTS IN SHOUCHI ENTERPRISE THROUGH PUBLIC TENDER AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by Overseas Chinese Town (Asia) Holdings Limited regarding a proposed mandate for a very substantial disposal involving partial interests in a subsidiary through a public tender. It includes a notice of an Extraordinary General Meeting (EGM) to approve the proposed disposal and mandate. The content includes definitions, a letter from the board, financial information appendices, property valuation, and general information, as well as a proxy form and detailed instructions for shareholders. The document is not a full financial report but a detailed circular related to a specific corporate action requiring shareholder approval. This fits the category of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings such as EGMs. The document is lengthy (15,000 characters) and contains substantive information for shareholders to make an informed decision, not merely an announcement or notice. Therefore, the appropriate classification is PSI with high confidence.
2022-10-24 English
UPDATES ON PROPOSED MANDATE FOR POTENTIAL VERY SUBSTANTIAL DISPOSAL AND POTENTIAL DISCLOSEABLE TRANSACTION INVOLVING SHOUCHI ENTERPRISE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding updates on a proposed mandate for a potential very substantial disposal and a potential discloseable transaction involving a subsidiary (Shouchi Enterprise). It details terms of joint venture arrangements, corporate governance, capital support, and operational management related to the disposal of equity interests. The content focuses on transaction updates, terms of agreements, and shareholder arrangements rather than financial results or detailed financial statements. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is not a call transcript, AGM material, or a regulatory certification. The document is a detailed update on a capital transaction and related arrangements, fitting the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2022-10-21 English
DISCLOSEABLE TRANSACTION - PURCHASE OF WEALTH MANAGEMENT PRODUCTS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the purchase of wealth management products by RemeGen Co., Ltd. It details multiple agreements with Qingdao Bank for purchasing principal-guaranteed wealth management products using idle raised proceeds from an A Share Offering. The document discusses the nature of these transactions, their aggregation under listing rules, and the implications for disclosure requirements. There is no presentation of financial statements, earnings data, or management discussion of financial results. Instead, it is a disclosure of a transaction related to the company's capital management and investment activities. This fits the category of Capital/Financing Update (CAP), as it updates on the company's use of raised capital and related financial transactions.
2022-10-21 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from the Board of Directors of RemeGen Co., Ltd. stating the date of a board meeting to consider and approve the unaudited third quarterly results for the nine months ended September 30, 2022. It does not contain the actual financial results or detailed financial data but rather informs about the upcoming meeting and the intention to publish the results. The document length is short (1515 characters) and serves as a notice rather than a report. According to the 'MENU VS MEAL' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2022-10-17 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-10-17 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-10-17 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.